Detalhe da pesquisa
1.
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Oncologist
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630540
2.
Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC).
J Cancer Educ
; 34(1): 14-18, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779441
3.
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer
; 124(18): 3677-3683, 2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30307610
4.
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies.
Eur Urol Oncol
; 7(3): 570-580, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097481
5.
Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol
; 2024 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290965
6.
Accuracy of germ cell tumor histology and stage within a Canadian cancer registry.
Can Urol Assoc J
; 17(2): 44-48, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36218319
7.
Perioperative systemic therapy in renal cell carcinoma.
Curr Opin Support Palliat Care
; 17(4): 301-307, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37800628
8.
Impact of the COVID-19 Pandemic on Medical Oncology Workload: A Provincial Review.
Curr Oncol
; 30(3): 3149-3159, 2023 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975451
9.
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma.
Eur Urol
; 84(1): 109-116, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707357
10.
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement.
Can Urol Assoc J
; 17(5): E154-E163, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185210
11.
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol Oncol
; 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914579
12.
Delivering Chemotherapy to a Metastatic Poor Risk Testicular Cancer Patient on Hemodialysis.
Curr Oncol
; 29(3): 1808-1812, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323348
13.
Uncommon case of metastatic prostate cancer developing cutaneous metastasis.
BMJ Case Rep
; 15(12)2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535736
14.
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System.
Adv Radiat Oncol
; 7(4): 100899, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35814860
15.
Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients.
Clin Genitourin Cancer
; 20(3): 210-218, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35115252
16.
Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial.
Eur Urol Oncol
; 5(2): 225-234, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244116
17.
Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma.
JAMA Netw Open
; 5(6): e2216379, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687336
18.
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy.
Eur J Cancer
; 171: 124-132, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717820
19.
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers.
Eur Urol Focus
; 8(6): 1703-1710, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34736870
20.
Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials.
Eur J Cancer
; 151: 115-125, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33975059